Study Questions Effectiveness of Budesonide for Preterm Infants with BPD
A recent study from the Royal Women’s Hospital reveals that combining budesonide with surfactant may not significantly improve survival rates free from bronchopulmonary dysplasia (BPD) in extremely preterm infants. Published in JAMA, the PLUSS trial involved over 1,000 infants and highlights the complexities of treating BPD, a common respiratory condition in preterm babies. Further research is essential to refine treatment protocols and enhance neonatal care.
Human Trials for Artificial Uterus Could Be Approved This Year
Scientists have announced human trials for an artificial uterus could be approved this year, bringing hope to the 15 million infants born prematurely each year in the US. A team at the Children’s Hospital of Philadelphia successfully tested the womb…